As leukemia development relies on clonal selection in xenograft [11], we hypothesized that the difference in aggressiveness between CD7+/CD34+ and CD7+/CD34− cells relates on the presence in both sub-fractions of distinct genetic subclones. Here, CD7 is linked to leukemia.